tiprankstipranks
Trending News
More News >
D.Western Therapeutics Institute, Inc. (DE:6DW)
FRANKFURT:6DW
Germany Market

D.Western Therapeutics Institute (6DW) Ratios

Compare
0 Followers

D.Western Therapeutics Institute Ratios

DE:6DW's free cash flow for Q4 2024 was ¥0.89. For the 2024 fiscal year, DE:6DW's free cash flow was decreased by ¥ and operating cash flow was ¥-4.58. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
9.07 11.02 12.59 11.19 11.93
Quick Ratio
8.75 10.57 12.21 10.73 11.65
Cash Ratio
8.14 9.62 11.05 10.01 11.00
Solvency Ratio
0.31 -0.70 -0.35 -0.24 -0.40
Operating Cash Flow Ratio
0.92 -3.02 -1.68 -0.91 -1.03
Short-Term Operating Cash Flow Coverage
1.46 -61.61 -2.96 -1.36 -1.80
Net Current Asset Value
¥ 1.14B¥ 1.04B¥ 1.58B¥ 1.73B¥ 1.93B
Leverage Ratios
Debt-to-Assets Ratio
0.24 0.37 0.33 0.14 0.17
Debt-to-Equity Ratio
0.34 0.69 0.52 0.17 0.21
Debt-to-Capital Ratio
0.26 0.41 0.34 0.14 0.18
Long-Term Debt-to-Capital Ratio
0.21 0.41 0.31 0.09 0.14
Financial Leverage Ratio
1.42 1.85 1.59 1.23 1.27
Debt Service Coverage Ratio
1.27 -64.69 -3.19 -0.83 -1.94
Interest Coverage Ratio
19.97 -320.71 -97.21 -38.80 -56.19
Debt to Market Cap
0.03 0.20 0.12 0.05 0.06
Interest Debt Per Share
18.49 27.93 32.75 11.74 17.10
Net Debt to EBITDA
-6.57 1.27 3.50 14.48 7.68
Profitability Margins
Gross Profit Margin
87.93%91.44%93.85%95.15%95.21%
EBIT Margin
19.89%-192.43%-97.55%-37.47%-80.09%
EBITDA Margin
27.82%-181.06%-87.20%-26.55%-67.67%
Operating Profit Margin
20.21%-186.42%-68.27%-41.42%-74.72%
Pretax Profit Margin
18.88%-193.01%-98.25%-38.54%-81.42%
Net Profit Margin
22.95%-189.65%-95.89%-35.95%-77.65%
Continuous Operations Profit Margin
18.60%-193.39%-98.61%-38.92%-81.87%
Net Income Per EBT
121.56%98.26%97.60%93.29%95.36%
EBT Per EBIT
93.40%103.54%143.92%93.05%108.98%
Return on Assets (ROA)
6.72%-34.23%-14.53%-6.05%-10.09%
Return on Equity (ROE)
9.56%-63.48%-23.13%-7.42%-12.76%
Return on Capital Employed (ROCE)
6.55%-36.64%-11.14%-7.56%-10.51%
Return on Invested Capital (ROIC)
6.05%-36.55%-10.72%-7.23%-10.09%
Return on Tangible Assets
7.69%-35.53%-15.17%-6.49%-10.92%
Earnings Yield
0.78%-18.13%-5.53%-2.35%-3.52%
Efficiency Ratios
Receivables Turnover
5.61 3.66 2.62 4.08 3.87
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
1.18 0.42 0.35 0.23 0.29
Fixed Asset Turnover
185.59 42.79 44.34 90.74 67.19
Asset Turnover
0.29 0.18 0.15 0.17 0.13
Working Capital Turnover Ratio
0.00 0.20 0.20 0.19 0.19
Cash Conversion Cycle
374.45 974.47 1.19K 1.69K 1.35K
Days of Sales Outstanding
65.09 99.82 139.09 89.55 94.31
Days of Inventory Outstanding
309.36 874.65 1.05K 1.61K 1.25K
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
374.45 974.47 1.19K 1.69K 1.35K
Cash Flow Ratios
Operating Cash Flow Per Share
6.66 -18.47 -11.97 -6.01 -7.96
Free Cash Flow Per Share
6.66 -18.94 -12.30 -6.11 -8.15
CapEx Per Share
0.00 0.47 0.33 0.10 0.19
Free Cash Flow to Operating Cash Flow
1.00 1.03 1.03 1.02 1.02
Dividend Paid and CapEx Coverage Ratio
0.00 -39.28 -36.15 -60.82 -42.19
Capital Expenditure Coverage Ratio
0.00 -39.28 -36.15 -60.82 -42.19
Operating Cash Flow Coverage Ratio
0.36 -0.66 -0.37 -0.52 -0.47
Operating Cash Flow to Sales Ratio
0.30 -1.37 -0.79 -0.43 -0.61
Free Cash Flow Yield
1.03%-13.43%-4.69%-2.83%-2.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
128.02 -5.52 -18.07 -42.53 -28.44
Price-to-Sales (P/S) Ratio
29.37 10.46 17.33 15.29 22.08
Price-to-Book (P/B) Ratio
12.24 3.50 4.18 3.16 3.63
Price-to-Free Cash Flow (P/FCF) Ratio
97.44 -7.45 -21.30 -35.36 -35.47
Price-to-Operating Cash Flow Ratio
97.44 -7.64 -21.89 -35.94 -36.31
Price-to-Earnings Growth (PEG) Ratio
0.00 -0.07 -0.10 0.85 0.09
Price-to-Fair Value
12.24 3.50 4.18 3.16 3.63
Enterprise Value Multiple
99.02 -4.51 -16.38 -43.10 -24.95
Enterprise Value
15.99B 3.50B 6.40B 4.74B 6.00B
EV to EBITDA
99.02 -4.51 -16.38 -43.10 -24.95
EV to Sales
27.55 8.17 14.28 11.44 16.89
EV to Free Cash Flow
91.38 -5.81 -17.55 -26.46 -27.12
EV to Operating Cash Flow
91.38 -5.96 -18.04 -26.90 -27.76
Tangible Book Value Per Share
44.11 37.55 59.01 63.70 71.97
Shareholders’ Equity Per Share
53.02 40.27 62.67 68.42 79.64
Tax and Other Ratios
Effective Tax Rate
0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
22.09 13.48 15.12 14.13 13.09
Net Income Per Share
5.07 -25.56 -14.50 -5.08 -10.16
Tax Burden
1.22 0.98 0.98 0.93 0.95
Interest Burden
0.95 1.00 1.01 1.03 1.02
Research & Development to Revenue
0.43 2.17 1.05 0.76 0.99
SG&A to Revenue
0.14 0.25 0.23 0.27 0.35
Stock-Based Compensation to Revenue
0.00 0.04 0.04 0.04 0.03
Income Quality
1.32 0.72 0.81 1.10 0.75
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis